Organization Overview
Historical Acquisition Tree
Alternative names
aducanumab (Aduhelm) (2021)
alefacept (Amevive) (2003 NDA)
daclizumab (Zenapax) (2016)
diroximel (Vumerity) (2019)
interferon beta-1a (Avonex) (1996)
acetaminophen (tylenol) (1 trial)
acetylsalicylic acid (aspirin) (3 trials)
alefacept (Amevive) (12 trials)
brimonidine (alphagan) (1 trial)
dalfampridine (ampyra) (10 trials)
doxycycline (vibramycin) (1 trial)
fingolimod (gilenya) (1 trial)
ibritumomab tiuxetan (Zevalin) (17 trials)
icosapent ethyl (vascepa) (1 trial)
interferon beta-1b (betaseron) (38 trials)
adalimumab (humira) (2 trials)
aducanumab (Aduhelm) (10 trials)
antihemophilic factor viii human (Hemofil M) (4 trials)
antihemophilic factor viii (Recombinant) (Adynovate) (2 trials)
antihemophilic factor viii (Recombinant), Fc-fusion protein (Eloctate) (4 trials)
baricitinib (olumiant) (1 trial)
coagulation factor ix (Recombinant) (Rixubis) (2 trials)
coagulation factor ix (Recombinant), Fc-fusion protein (Alprolix) (4 trials)
cyclophosphamide (cytoxan) (8 trials)
daclizumab (Zenapax) (9 trials)
dextromethorphan (delsym) (1 trial)
diroximel (Vumerity) (2 trials)
cyclosporine (sandimmune) (1 trial)
cytarabine (cytosar-u) (1 trial)
doxorubicin (Doxil) (3 trials)
etanercept (enbrel) (2 trials)
etoposide (vepesid) (2 trials)
immune globulin (human) (Gamastan) (1 trial)
inactivated influenza vaccine (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi) (1 trial)
mitoxantrone (novantrone) (2 trials)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)
Adenocarcinoma (Phase 2)
AIDS-Related Complex (Phase 2)
Alzheimer Disease (Phase 3)
Amyloidosis (Phase 3)
Amyotrophic Lateral Sclerosis (Phase 3)
Arthritis (Phase 3)
Arthritis, Psoriatic (Phase 2)
Arthritis, Rheumatoid (Phase 3)
Astrocytoma (Phase 1)
Atrophy (Phase 4)
Autoimmune Diseases (Phase 1)
Brain Contusion (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Ovarian Epithelial (Phase 2)
Cerebellar Diseases (Phase 4)
Cerebral Infarction (Phase 2)
Churg-Strauss Syndrome (Phase 2)
Cognitive Dysfunction (Phase 2)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Colorectal Neoplasms (Phase 2)
Connective Tissue Diseases (Phase 1)
Contusions (Phase 2)
Crohn Disease (Phase 4)
Dementia (Phase 2)
Demyelinating Diseases (Phase 1)
Dermatomyositis (Phase 2)
Diabetes Mellitus (Phase 2)
Diabetic Neuropathies (Phase 1)
Disease Progression (Phase 1)
Epilepsies, Partial (Phase 2)
Epilepsy (Phase 2)
Erythema (Phase 4)
Fatigue (Phase 4)
Fibrosis (Phase 2)
Flushing (Phase 4)
Gastrointestinal Stromal Tumors (Phase 2)
Glioblastoma (Phase 1)
Glioma (Phase 1)
Gliosarcoma (Phase 1)
Glomerulonephritis, IGA (Phase 4)
Graft vs Host Disease (Phase 2)
Heart Failure (Phase 3)
Hemophilia A (Phase 3)
Hemophilia B (Phase 3)
HIV Infections (Phase 1)
Hypertension (Phase 1)
Hypertension, Pulmonary (Phase 1)
Hyponatremia (Phase 3)
Idiopathic Pulmonary Fibrosis (Phase 2)
Immune System Diseases (Phase 1)
Ischemia (Phase 2)
Kidney Diseases (Phase 4)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukoencephalopathies (Phase 4)
Lichen Planus (Phase 2)
Liver Diseases (Phase 1)
Lung Neoplasms (Phase 1)
Lupus Erythematosus, Cutaneous (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Lupus Nephritis (Phase 2)
Lymphoma (Phase 4)
Lymphoma, B-Cell (Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 4)
Melanoma (Phase 2)
Mesothelioma (Phase 1)
Motor Neuron Disease (Phase 3)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 4)
Multiple Sclerosis, Chronic Progressive (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 4)
Multiple System Atrophy (Phase 1)
Muscular Atrophy (Phase 4)
Muscular Atrophy, Spinal (Phase 4)
Myelitis (Phase 4)
Myelitis, Transverse (Phase 4)
Myositis (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Nephritis (Phase 2)
Neuralgia (Phase 3)
Neuritis (Phase 4)
Optic Neuritis (Phase 4)
Ovarian Neoplasms (Phase 2)
Pain (Phase 2)
Paraproteinemias (Phase 2)
Parkinson Disease (Phase 2)
Pemphigoid, Benign Mucous Membrane (Phase 2)
Pemphigoid, Bullous (Phase 2)
Peripheral Nervous System Diseases (Phase 2)
Peritoneal Neoplasms (Phase 2)
Pleural Effusion (Phase 1)
Polymyositis (Phase 2)
Polyneuropathies (Phase 1)
Polyradiculoneuropathy (Phase 2)
Precancerous Conditions (Phase 2)
Psoriasis (Phase 4)
Pulmonary Fibrosis (Phase 2)
Purpura (Phase 3)
Purpura, Thrombocytopenic (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 3)
Radiculopathy (Phase 2)
Renal Insufficiency (Phase 3)
Schizophrenia (Phase 2)
Sciatica (Phase 2)
Scleroderma, Diffuse (Phase 1)
Scleroderma, Systemic (Phase 1)
Sclerosis (Phase 4)
Seizures (Phase 2)
Shy-Drager Syndrome (Phase 1)
Sjogren's Syndrome (Phase 2)
Sleepiness (Phase 4)
Small Fiber Neuropathy (Phase 2)
Stroke (Phase 2)
Syndrome (Phase 4)
Trigeminal Neuralgia (Phase 3)
Ulcer (Phase 2)